Palmetto Retina Center

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 982 citations · Full text

Diabetic Retinopathy, Ocular Disease, Ophthalmology +4

Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials

The Lancet · 2022 · 391 citations

Ocular Disease, Vitreous Body, Ophthalmology +4

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion

Peter A. Campochiaro, W. Lloyd Clark, David S. Boyer et al. · Ophthalmology · 2014 · 374 citations

Ocular Disease, Vitreous Body, Ophthalmology +4

Program of All‐inclusive Care for the Elderly (PACE): An Innovative Model of Integrated Geriatric Care and Financing

Catherine Eng, James Pedulla, G. Paul Eleazer et al. · Journal of the American Geriatrics Society · 1997 · 371 citations

Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study

David M. Brown, Jeffrey S. Heier, W. Lloyd Clark et al. · American Journal of Ophthalmology · 2012 · 360 citations

Ocular Disease, Vitreous Body, Intravitreal Aflibercept Injection +6